Detalhe da pesquisa
1.
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial.
Lancet
; 401(10373): 281-293, 2023 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36566761
2.
Numerical Distributions of Parasite Densities During Asymptomatic Malaria.
J Infect Dis
; 213(8): 1322-9, 2016 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26681777
3.
The epidemiology of subclinical malaria infections in South-East Asia: findings from cross-sectional surveys in Thailand-Myanmar border areas, Cambodia, and Vietnam.
Malar J
; 14: 381, 2015 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-26424000
4.
Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease.
BMJ Open
; 13(8): e069176, 2023 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37550022
5.
H1N1 antibody persistence 1 year after immunization with an adjuvanted or whole-virion pandemic vaccine and immunogenicity and reactogenicity of subsequent seasonal influenza vaccine: a multicenter follow-on study.
Clin Infect Dis
; 54(5): 661-9, 2012 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22267719
6.
T-cell responses in children to internal influenza antigens, 1 year after immunization with pandemic H1N1 influenza vaccine, and response to revaccination with seasonal trivalent-inactivated influenza vaccine.
Pediatr Infect Dis J
; 31(6): e86-91, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22466328